Alzheimer’s disease (AD) is a neuro-degenerative disorder which is characterised functional and cognitive deficits that take place progressively. Early detection of the AD is important for the therapy to be early and this may slow down the disease and its progression. For the purpose of bringing about an improvement to the incidence of early detection of the AD, there may be certain Normal Controls (NC) that is based on the structural analysis of Magnetic Resonance Imaging (MRI). In fact, an early detection of the AD by means of using an MRI can help both patients, as well as physicians, to a great extent since it is of a low cost and is also a procedure that is non-invasive providing objective diagnosis by avoiding human errors. This has been connected to the accumulation of the amyloid and the tau proteins found in the brain which is probably the commonest cause for a case of dementia and also accounts for almost 70% of cases of dementia. The MRI is an extremely promising technique in terms of detection of functional or structural brain differences observed among both these patient populations. For the purpose of this work, there had been a new survey that had been made for the identification of a new case of Alzheimer’s disease by means of using the MRI images.
Magnetic Resonance Imaging Improves Cerebrospinal Fluid Biomarkers in the Early Detection of Alzheimer's Disease
